was read the article
array:24 [ "pii" => "S2013251420301371" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2019.11.005" "estado" => "S300" "fechaPublicacion" => "2020-11-01" "aid" => "691" "copyright" => "Sociedad Española de Nefrología" "copyrightAnyo" => "2020" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2020;40:680" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:20 [ "pii" => "S2013251420301553" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2019.12.009" "estado" => "S300" "fechaPublicacion" => "2020-11-01" "aid" => "692" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2020;40:681-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Don’t forget syphilis in membranous nephropathy before immunosuppressants: Latent syphilis in a patient with proteinuria" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "681" "paginaFinal" => "682" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "No olvide la sífilis en la nefropatía membranosa antes de los inmunosupresores" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 720 "Ancho" => 955 "Tamanyo" => 198650 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Renal biopsy which display glomeruli with basal membrane thickening and enhanced mesangial matrix H.E. ×200.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Kubra Kaynar, Beyhan Güvercin, Sevdegül Mungan, Şükrü Ulusoy" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Kubra" "apellidos" => "Kaynar" ] 1 => array:2 [ "nombre" => "Beyhan" "apellidos" => "Güvercin" ] 2 => array:2 [ "nombre" => "Sevdegül" "apellidos" => "Mungan" ] 3 => array:2 [ "nombre" => "Şükrü" "apellidos" => "Ulusoy" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0211699520300072" "doi" => "10.1016/j.nefro.2019.12.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699520300072?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251420301553?idApp=UINPBA000064" "url" => "/20132514/0000004000000006/v1_202012250708/S2013251420301553/v1_202012250708/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S2013251420301486" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2019.11.007" "estado" => "S300" "fechaPublicacion" => "2020-11-01" "aid" => "690" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2020;40:678-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Pembrolizumab in hemodialysis patients. Is it safe?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "678" "paginaFinal" => "679" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Pembrolizumab en pacientes en hemodiálisis ¿es seguro?" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Melisa Guzmán Vasquez, Andrea Patricia Zapata Balcázar, Daniel Germán Gaitán Tocora, Concepción Álamo Caballero, José Ramón Rodríguez Palomares, Marta Sánchez Heras, Gabriel de Arriba de La Fuente" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Melisa" "apellidos" => "Guzmán Vasquez" ] 1 => array:2 [ "nombre" => "Andrea Patricia" "apellidos" => "Zapata Balcázar" ] 2 => array:2 [ "nombre" => "Daniel Germán" "apellidos" => "Gaitán Tocora" ] 3 => array:2 [ "nombre" => "Concepción" "apellidos" => "Álamo Caballero" ] 4 => array:2 [ "nombre" => "José Ramón" "apellidos" => "Rodríguez Palomares" ] 5 => array:2 [ "nombre" => "Marta" "apellidos" => "Sánchez Heras" ] 6 => array:2 [ "nombre" => "Gabriel" "apellidos" => "de Arriba de La Fuente" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0211699520300059" "doi" => "10.1016/j.nefro.2019.11.007" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699520300059?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251420301486?idApp=UINPBA000064" "url" => "/20132514/0000004000000006/v1_202012250708/S2013251420301486/v1_202012250708/en/main.assets" ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Reply to Letter to the Editor</span>" "titulo" => "Two birds with one stone: Anakinra for both gout and Familial Mediterranean fever attacks in a patient with renal transplant" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "680" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Meltem Alkan Melikoglu" "autores" => array:1 [ 0 => array:3 [ "nombre" => "Meltem Alkan" "apellidos" => "Melikoglu" "email" => array:1 [ 0 => "mamelikoglu@gmail.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Ataturk University, Faculty of Medicine, Physical Medicine and Rehabilitation, Rheumatology Department, Erzurum, Turkey" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Dos pájaros de un tiro: anakinra para la gota y ataques de fiebre mediterránea familiar en un paciente con trasplante renal" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We read the valuable manuscript of Hasbal NM et al. entitled “A familial Mediterranean fever patient with double homozygous mutations treated with anakinra after kidney transplantation”.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a> We aimed to contribute their study by sharing our follow-up experience with anakinra for both gout and Familial Mediterranean fever (FMF) attacks in a case with renal transplantation (Tx).</p><p id="par0010" class="elsevierStylePara elsevierViewall">A 48 year-old male patient with a history of renal Tx (20 years ago) due to amyloidosis caused by FMF have presented severe FMF attacks in spite of optimal dose and regular colchicine. He also presented severe acute gout attacks due to high uric acid level associated with impaired renal function. Nonsteroidal anti-inflammatory drugs could not be used due to increased serum creatinine levels. Anakinra was selected for both FMF attacks and acute gout attacks in this case. During his five-year follow-up period, both FMF and gout attacks were managed successfully without any adverse reactions.</p><p id="par0015" class="elsevierStylePara elsevierViewall">FMF is an autosomal recessive disease caused by mutations in the FMF gene (Mediterranean fever; MEFV) and characterized by recurrent episodes of fever and sterile peritonitis, arthritis and/or pleuritis lasting 1–4 days. Although the standard treatment of FMF is colchicine, in different studies it has been reported that about 5–15% of patients with FMF do not respond to treatment with colchicine.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">2,3</span></a> Since the central role in the inflammation flares is played by interleukin 1β (IL-1β), anti-IL-1 agents such as anakinra, rilonacept and canakinumab represent another important therapeutic strategy for these patients.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">4</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Anti IL-1 agents also have been shown to be effective in the treatment of patients with acute gout and they have been recommended in patients with frequent flares and contraindications to conventional treatments.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">5</span></a> Again, IL-1β plays a central role in monosodium urate crystal-induced inflammation and its blockade represents an effective strategy for acute gout flares. However, data on the safety and efficacy of IL-1 inhibition in gout flares are lacking in patients with advanced renal failure and in patients with renal tx since this population has been excluded from clinical studies. This leads to a need in presenting case reports results in these population. We again to thank Hasbal et al. for sharing their experience with anakinra in a case with renal tx.</p><p id="par0025" class="elsevierStylePara elsevierViewall">In our case with renal tx, anakinra was administered for “two birds with one stone” for 5 years and both FMF and gout attacks were managed successfully without any adverse reactions.</p><p id="par0030" class="elsevierStylePara elsevierViewall">In conclusion, our result may contribute to the literature by presenting safe and successful prevention of both FMF and gout attacks with anakinra in our case with renal Tx.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0035" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A familial Mediterranean fever patient with double homozygous mutations treated with anakinr aafter kidney transplantation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "N.B. Hasbal" 1 => "Y. Koc" 2 => "M. Sevinc" 3 => "A. Unsal" 4 => "T. Basturk" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nefro.2020.06.006" "Revista" => array:5 [ "tituloSerie" => "Nefrologia" "fecha" => "2019" "paginaInicial" => "S0211" "paginaFinal" => "S6995" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33032839" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0040" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "IL1-blocking therapy in colchicine-resistant familial Mediterranean fever" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B.M. Köhler" 1 => "H.M. Lorenz" 2 => "N. Blank" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5152/eurjrheum.2018.18036" "Revista" => array:6 [ "tituloSerie" => "Eur J Rheumatol" "fecha" => "2018" "volumen" => "5" "paginaInicial" => "230" "paginaFinal" => "234" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30501849" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0045" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Non-response to colchicine in familial Mediterranean fever should be identified accurately" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M.A. Melikoglu" 1 => "K. Senel" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Int J Rheum Dis" "fecha" => "2017 Dec" "volumen" => "20" "paginaInicial" => "2118" "paginaFinal" => "2121" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0050" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Ozen F, Silan C, Uludag A, Candan F, Silan F, Ozdemir S, et al. Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients. Ren Fail 33:899–903." ] ] ] 4 => array:3 [ "identificador" => "bib0055" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Canakinumab as monotherapy for treatment of familial Mediterranean fever – first report in Central and Eastern Europe region" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Jesenak" 1 => "K. Hrubiskova" 2 => "L. Kapustova" 3 => "M. Kostkova" 4 => "P. Banovcin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4149/BLL_2018_036" "Revista" => array:6 [ "tituloSerie" => "Bratisl Lek Listy" "fecha" => "2018" "volumen" => "119" "paginaInicial" => "198" "paginaFinal" => "200" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29663815" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000004000000006/v1_202012250708/S2013251420301371/v1_202012250708/en/main.assets" "Apartado" => array:4 [ "identificador" => "35436" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000004000000006/v1_202012250708/S2013251420301371/v1_202012250708/en/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251420301371?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 5 | 7 | 12 |
2024 October | 41 | 38 | 79 |
2024 September | 37 | 32 | 69 |
2024 August | 53 | 61 | 114 |
2024 July | 32 | 26 | 58 |
2024 June | 41 | 37 | 78 |
2024 May | 42 | 30 | 72 |
2024 April | 40 | 34 | 74 |
2024 March | 59 | 37 | 96 |
2024 February | 40 | 38 | 78 |
2024 January | 22 | 24 | 46 |
2023 December | 18 | 26 | 44 |
2023 November | 33 | 37 | 70 |
2023 October | 55 | 23 | 78 |
2023 September | 62 | 29 | 91 |
2023 August | 41 | 24 | 65 |
2023 July | 28 | 18 | 46 |
2023 June | 33 | 20 | 53 |
2023 May | 34 | 27 | 61 |
2023 April | 22 | 15 | 37 |
2023 March | 38 | 18 | 56 |
2023 February | 27 | 10 | 37 |
2023 January | 40 | 30 | 70 |
2022 December | 40 | 37 | 77 |
2022 November | 39 | 21 | 60 |
2022 October | 43 | 40 | 83 |
2022 September | 32 | 27 | 59 |
2022 August | 25 | 37 | 62 |
2022 July | 40 | 49 | 89 |
2022 June | 29 | 45 | 74 |
2022 May | 48 | 27 | 75 |
2022 April | 33 | 62 | 95 |
2022 March | 55 | 49 | 104 |
2022 February | 32 | 39 | 71 |
2022 January | 46 | 36 | 82 |
2021 December | 32 | 35 | 67 |
2021 November | 46 | 36 | 82 |
2021 October | 62 | 53 | 115 |
2021 September | 32 | 33 | 65 |
2021 August | 61 | 37 | 98 |
2021 July | 40 | 31 | 71 |
2021 June | 44 | 22 | 66 |
2021 May | 32 | 40 | 72 |
2021 April | 65 | 60 | 125 |
2021 March | 59 | 46 | 105 |
2021 February | 30 | 34 | 64 |
2021 January | 32 | 29 | 61 |
2020 December | 3 | 2 | 5 |